Follow us on twitter Follow us on X

High prevalence of low faecal elastase levels in individuals with type 1 diabetes is associated with diabetes duration but not with marked alterations in food intake or clinical symptoms – published online 08/08/2026

de Wit graphical abstract

Douwe F. de Wit, Coco M. Fuhri Snethlage, Johannes H. M. Levels, Elena Rampanelli, Abraham S. Meijnikman, Max Nieuwdorp, Nordin M. J. Hanssen

Low faecal elastase (FE) levels are reported in up to 50% of individuals with type 1 diabetes, but it is unclear whether this reflects clinically relevant exocrine pancreatic insufficiency (EPI). In this issue, de Wit et al (https://doi.org/10.1007/s00125-026-06829-9) investigate the relationship between FE levels and diabetes duration, age and clinical parameters in a cross-sectional cohort of 443 individuals with type 1 diabetes. Older age, longer diabetes duration, higher HbA1c, male sex and smoking were independently associated with lower FE levels. However, the authors found no association with abdominal complaints, liver disease or residual beta cell function. When dichotomising FE levels according to international guidelines, the authors reported an EPI prevalence of 17% at low FE levels, and this was associated with worse glycaemic management and lower fibre and total energy intake. The authors conclude that, altogether, these findings do not support routine FE screening as a marker of EPI in clinical practice. However, they underscore the need for clinical awareness of EPI and its complications, especially in individuals with a longer type 1 diabetes duration. The authors also highlight that, although the association between low FE levels and HbA1c was cross-sectional, this intriguing finding may be deserving of further research.

All News
Top